TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ARMP

Armata Pharmaceuticals Inc

Healthcare · Biotechnology

3.70$ +3.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Armata Pharmaceuticals Inc (ARMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 90 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARMP
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
113 98 120 108 98 86 87 81 90 77 70 90
37 19 42 31 22 11 13 7.5 17 11 5.9 27
24 14 38 26 17 9.3 12 4.3 15 8.7 4.8 24
24 14 38 26 17 9.3 12 4.3 15 8.7 4.8 24
8.5 3.4 1.7 1.2 2.2 0.7 0.2 2.2 0.8 0.5 0.0 2.5
– – -1.7 – – – – – – – – –
3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5
10 10 10 10 10 10 10 10 10 10 10 10
125 130 177 154 149 134 141 150 185 295 381 321
22 16 110 123 118 48 111 120 140 8.9 9.2 250
13 9.5 104 118 112 43 107 117 136 4.6 4.6 246
3.8 1.6 2.1 1.7 1.8 0.8 1.0 1.0 1.3 0.9 0.7 1.2
72 82 35 – – 55 – – 15 257 343 –
-12 -32 -57 -46 -51 -48 -54 -70 -96 -219 -312 -231
-289 -309 -334 -325 -330 -328 -334 -351 -377 -502 -617 -543
36 36 36 58 36 59 36 36 36 36 37 62

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?